Ayurvedic Treatment Protocol in the Management of Obese Polycystic Ovarian Disease
- Conditions
- Health Condition 1: N915- Oligomenorrhea, unspecifiedHealth Condition 2: N915- Oligomenorrhea, unspecified
- Registration Number
- CTRI/2023/04/051423
- Lead Sponsor
- STITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Married /unmarried patients in the age group of 18-40yrs
2. Patients with BMI >=30kg/m2
3. Patients with any 3 or more clinical features of PCOD like-
• Amenorrhea or Oligomenorrhoea
• Anovulation
• Infertility (Due to anovulation)
• Acne
• Hirsutism (Ferryman-Gallwey scale)
• Acanthosis nigricans.
4. Along with confirmation of Polycystic Ovary in USG finding
1. Patients having age <= 18years and >=40years.
2. Patient with infectious diseases of reproductive tract like tuberculosis, sexually
transmitted diseases.
3. Patients suffering from Pelvic diseases like Endometriosis, PID, Fibroid uterus.
4. Organic lesions of reproductive tract like tuberculosis, carcinoma and congenital
deformities.
5. Patients with history of cardiac diseases, Chronic liver disease, Uncontrolled Diabetes
(>=160 mg/dl- FBS) & Hypertension (Systolic BP >=160 & Diastolic >=100mmhg), TB, etc
6. Patient with Hepatitis C, Hepatitis B
7. Patient not eligible for Virechana Karma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that trial drug will help in the reduction of ovarian volume,weight reduction and <br/ ><br>menstrual regulation.Timepoint: 120 days
- Secondary Outcome Measures
Name Time Method Trial drug will help in ovulation & conception.Timepoint: 120 days